Effects of glucagon-like peptide-1 receptor agonists on major coronary events in patients with type 2 diabetes.

Xueyuan Guo,Caihua Sang,Ribo Tang,Chenxi Jiang,Songnan Li,Nian Liu,Deyong Long,Xin Du,Jianzeng Dong,Changsheng Ma

Diabetes, obesity & metabolism（2023）

引用 1|浏览55

暂无评分

摘要

In high-risk patients with T2DM, GLP-1RAs were associated with a decrease in MI, especially the human-based and once-weekly GLP-1RAs. No benefit was seen for hospitalization for unstable angina or coronary revascularization. Further research is urgently needed to ascertain improvements in coronary events.

查看译文

关键词

coronary events,glucagon-like peptide-1 receptor agonists,meta-analysis,type 2 diabetes mellitus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要